Identifying and hurdling obstacles to translational research

Nature Reviews Immunology

Volumn 7, Issue 1, 2007, Pages 77-82

  Sabroe, Ian ^a   Dockrell, David H ^a   Vogel, Stefanie N ^b   Renshaw, Stephen A ^a   Whyte, Moira K B ^a   Dower, Steven K ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOINFORMATICS; BIOMEDICINE; CYTOKINE RELEASE; ETHICS; HEALTH CARE POLICY; IMMUNOLOGY; MEDICAL RESEARCH; MOLECULAR BIOLOGY; PRIORITY JOURNAL; REVIEW;

ANIMALS; BIOMEDICAL RESEARCH; DISEASE MODELS, ANIMAL; HUMANS;

EID: 33845903333     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri1999     Document Type: Review

References (34)

1. Krause, D. S. & Van Etten, R. A. Tyrosine kinases as targets for cancer therapy. N. Engl. J. Med. 353, 172-187 (2005).
2. Levine, M. N. & Whelan, T. Adjuvant chemotherapy for breast cancer - 30 years later. N. Engl. J. Med. 355, 1920-1922 (2006).
3. Gelfand, E. W. Pro: mice are a good model of human airway disease. Am. J. Respir. Crit. Care Med. 166, 5-6; discussion 7-8 (2002).
4. Gordon, C. J., Grafton, G., Wood, P. M., Larche, M. & Armitage, R. J. Modelling the human immune response: can mice be trusted? Commentary. Curr. Opin. Pharmacol. 1, 431-435 (2001).
5. Kumar, R. K. & Foster, P. S. Modeling allergic asthma in mice: pitfalls and opportunities. Am. J. Respir. Cell Mol. Biol. 27, 267-272 (2002).
6. Persson, C. G. Con: mice are not a good model of human airway disease. Am. J. Respir. Crit. Care Med. 166, 6-7; discussion 8 (2002).
7. Persson, C. G., Erjefalt, J. S., Korsgren, M. & Sundler, F. The mouse trap. Trends Pharmacol. Sci. 18, 465-467 (1997).
8. Roep, B. O., Atkinson, M. & von Herrath, M. Satisfaction (not) guaranteed: re-evaluating the use of animal models of type 1 diabetes. Nature Rev. Immunol. 4, 989-997 (2004).
9. Wiles, S., Hanage, W. P., Frankel, G. & Robertson, B. Modelling infectious disease - time to think outside the box? Nature Rev. Microbiol. 4, 307-312 (2006).
10. von Herrath, M. G. & Nepom, G. T. Lost in translation: barriers to implementing clinical immunotherapeutics for autoimmunity. J. Exp. Med. 202, 1159-1162 (2005).
11. Medvedev, A. E. et al. Distinct mutations in IRAK-4 confer hyporesponsiveness to lipopolysaccharide and interleukin-1 in a patient with recurrent bacterial infections. J. Exp. Med. 198, 521-531 (2003).
12. Picard, C. et al. Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 299, 2076-2079 (2003).
13. Suzuki, N. et al. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature 416, 750-756 (2002).
14. Wenzel, S. E. Phenotypes in asthma: useful guides for therapy, distinct biological processes, or both? Am. J. Respir. Crit. Care Med. 170, 579-580 (2004).
15. Wenzel, S. E. et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am. J. Respir. Crit. Care Med. 160, 1001-1008 (1999).
16. Nguyen, D. H., Hurtado-Ziola, N., Gagneux, P. & Varki, A. Loss of Siglec expression on T lymphocytes during human evolution. Proc. Natl Acad. Sci. USA 103, 7765-7770 (2006).
17. Cohen, J. Immunology. Differences in immune cell 'brakes' may explain chimp-human split on AIDS. Science 312, 672-673 (2006).
18. Suntharalingam, G. et al. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N. Engl. J. Med. 355, 1018-1028 (2006).
19. Barrett, G., Cassell, J. A., Peacock, J. L. & Coleman, M. P. National survey of British public's views on use of identifiable medical data by the National Cancer Registry. BMJ 332, 1068-1072 (2006).
20. Lin, Z., Altman, R. B. & Owen, A. B. Confidentiality in genome research. Science 313, 441-442 (2006).
21. McGuire, A. L. & Gibbs, R. A. Genetics. No longer de-identified. Science 312, 370-371 (2006).
22. Shinagawa, K. & Kojima, M. Mouse model of airway remodeling: strain differences. Am. J. Respir. Crit. Care Med. 168, 959-967 (2003).
23. Kips, J. C. et al. Murine models of asthma. Eur. Respir. J. 22, 374-382 (2003).
24. Brand, D. D. Rodent models of rheumatoid arthritis. Comp. Med. 55, 114-122 (2005).
25. Fan, C. et al. Concordance among gene-expression-based predictors for breast cancer. N. Engl. J. Med. 355, 560-569 (2006).
26. Potti, A. et al. A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N. Engl. J. Med. 355, 570-580 (2006).
27. Kwok, T. C. et al. A small-molecule screen in C. elegans yields a new calcium channel antagonist. Nature 441, 91-95 (2006).
28. Zon, L. I. & Peterson, R. T. In vivo drug discovery in the zebrafish. Nature Rev. Drug Discov. 4, 35-44 (2005).
29. Renshaw, S. A. et al. A transgenic zebrafish model of neutrophilic inflammation. Blood (in the press).
30. Griffith, L. G. & Swartz, M. A. Capturing complex 3D tissue physiology in vitro. Nature Rev. Mol. Cell Biol. 7, 211-224 (2006).
31. Morris, G. E. et al. Cooperative molecular and cellular networks regulate Toll-like receptor-dependent inflammatory responses. FASEB J. 20, 2153-2155 (2006).
32. Morris, G. E. et al. Agonists of Toll-like receptors 2 and 4 activate airway smooth muscle via mononuclear leukocytes. Am. J. Respir. Crit. Care Med. 171, 814-822 (2005).
33. Sabroe, I. et al. Pulmonary perspective: targeting the networks that underpin contiguous immunity in asthma and COPD. Am. J. Respir. Crit. Care Med. (in the press).
34. Nobeli, I. & Thornton, J. M. A bioinformatician's view of the metabolome. BioEssays 28, 534-545 (2006).